DeJarnette moves VisiShare closer to general availabilityDeJarnette Research Systems placed its Windows NT-based VisiShare workstation software into beta testing in June at the University of Pennsylvania Medical Center in Philadelphia. General
DeJarnette Research Systems placed its Windows NT-based VisiShare workstation software into beta testing in June at the University of Pennsylvania Medical Center in Philadelphia. General availability is expected by the end of this month for the workstation line, which received Food and Drug Administration 510(k) clearance prior to the 1997 Radiological Society of North America meeting (
PNN
12/97).
DeJarnette believes that the sparseness of the VisiShare interface as well as the ability to perform important functions with one mouse click will play well in the market. As with its ImageShare CR quality assurance offering, DeJarnette is interested in selling the product on an OEM basis, but will also sell direct to government clients and to other customers in some situations, said president Wayne DeJarnette.
In other product news, DeJarnette is experiencing healthy sales of the second generation of its ImageShare CR offering. The latest release of ImageShare CR has been installed at six sites since shipments began in May, and the Towson, MD-based firm has a backlog of 15 systems.
In addition to direct sales of ImageShare CR to customers like the military and the VA, the company has an OEM distribution agreement with Picker International.
In the fourth quarter of this year, DeJarnette expects to release a bi-directional interface for ImageShare CR. The interface, called DeJarnette Interface Board, will also be used in the company's LaserShare DICOM network print server.
The company has also completely converted its products to PC-based offerings, running either on Windows NT or Solaris x86, Sun's Unix adaptation for PCs. DeJarnette will be converting the entire product line to NT over the next year, although, from a technology standpoint, the company would prefer to stick with the Solaris x86 operating environment, he said. It has run identical applications using either NT or Solaris x86 on the same computer and found that the Solaris-based program was faster.
"Right now NT is an inferior product to Solarix x86 on the same platform," DeJarnette said. "But the marketplace wants NT."
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.
2 Commerce Drive
Cranbury, NJ 08512